a

NuVasive Receives Premarket Approval of Cervical Spine Disc System

Written by  Jaimie Oh | October 29, 2012
Social sharing
NuVasive has received premarket approval of its PCM Cervical Disc System from the FDA.
The PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7. The device is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment prior to implantation.

More Articles on Orthopedic Devices:

New Instrumentation & Partnership for DePuy Synthes Spine
DePuy Synthes Spine Launches Minimally Invasive Posterior-Lateral Fusion System
10 Orthopedic Device Company Acquisitions
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus